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Protein dynamics, particularly, intrinsic protein disorder has been implicated in 
cellular functions. Intrinsic protein disorder contributes to transcription and cell 
signalling through the accommodation of multiple interaction partners and 
modification sites, and provision of regulation flexibility. Here, in support with 
previous studies, I hypothesize that analogous with sequence conservation of 
functionally important sites, intrinsic protein disorder properties are evolutionary 
conserved.  
To further support and test this hypothesis, in the more specific context of 
transcriptional regulation in cell signaling, I developed an in silico analysis pipeline 
for the identification of intrinsically disordered protein residues, data mining and in-
depth analysis of the conservation, localization and function of predicted disordered 
regions. The Nuclear Factor Kappa-light-chain-enhancer of Activated B cells 
(NFκB/Rel), important for a variety of processes including cell survival, inflammation 
and immunity, was chosen as the exemplar protein for this study.  
The findings highlight distinctive key roles of conserved disordered and non-
disordered in different aspects of NFκB function. Differences in the distribution and 
conservation patterns of protein disorder in each NFκB protein type raise the 
possibility of conserved disorder signatures in different protein families, which, if 
true, will prove valuable for functional characterization.  
On a larger scale, this project shows a meaningful perspective for the understanding 
of protein function, through intrinsic protein disorder. The analysis pipeline developed 
in this study will be instrumental for large-scale functional studies of protein families. 
Findings from this project will also contribute to scientific knowledge in 
transcriptional regulation and cell signaling.                           
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1.1 Protein Dynamics 
Protein structures are dynamic in nature and undergo motion – a property that is an 
integral part of their function[1-3].  
Protein dynamics (or protein motion) occurs over a wide range of amplitudes and 
timescales. For example, simple local internal motions, such as bond and angle 
rotations, occur on a femto- to picosecond timescale[4]. Side-chain and loop motions 
occur on a pico- to nanosecond time scale, while global external motions involving 
large-scale conformational rearrangements occur on a micro- to millisecond 
timescale[5,6]. Molecular interactions and binding occur on the second timescale 
(Table 1)[2]. Additionally, complex, orchestrated protein motion, such as those 
involving molecular motors has also been observed[3].  
 
Table 1. Ranges of timescales and amplitudes where protein dynamics have been reported to occur. 
Timescale Examples Amplitude 
Femtosecond Bond and angle vibrations < 0.001 - 0.1 Å 
Picosecond Side chain rotations 0.1 - 1 Å 
Nanosecond Hinge bending at domain interfaces 1 – 10 Å 
Microsecond Helix-coil transitions 10 Å - 100 Å 
Millisecond Protein folding, actin-myosin motion 10 Å - 100 Å 





Figure 1. The two types of protein dynamics (or protein motions) and their distribution, relative to protein 
structure. 
 
Across timescales and amplitudes, protein dynamics can be broadly categorized into 
internal and external motion[7]. Internal motion involves the deformation of protein 
segment(s) such as bond, angle or side-chain rotations[7]. External motion, on the 
other hand, encompasses the translational and rotational motions of protein 
segment(s), such as hinge and shear motion, involving the protein backbone (Figure 
1)[7,8]. 
Besides well-structured, ordered regions of proteins, protein dynamics have also been 
studied in non-globular, unstructured and/or flexible regions (to be referred to as 
intrinsically disordered regions)[9], where they contribute to a number of important 
functions. Intrinsically disordered regions will be described in detail in Section 1.2. 
 
1.2 Functional Significance of Protein Dynamics 
Protein dynamics are fundamentally involved in important biological events, such as 
protein folding, conformational changes and protein-protein interactions[2]. These 




An example is the crucial role of protein dynamics in muscle contraction[6]. Muscle 
contraction involves the cross-bridge cycle, with the first step involving adenosine 
triphosphate (ATP) binding to the myosin head. Binding of the myosin head to actin 
myofilaments, and calcium to the complex, leads to changes in electrostatic charges 
and cross-bridge formation. Subsequent hydrolysis of ATP to adenosine triphosphate 
(ADP) alters the conformation of the head of the cross-bridge and produces energy for 
the pulling movement of the actin filament towards the centre of the cell. Finally, the 
release of ADP disrupts binding with the actin filament and restarts the cycle with the 
next ATP binding event, in the presence of calcium ions. 
At a smaller scale, protein dynamics is also involved in human immunodeficiency 
virus (HIV) infection[12]. This is mediated through the binding of the envelope 
glycoprotein, gp120, to a c (CD4) receptor. Briefly, the binding event causes 
conformational changes in gp120, in turn promoting the binding of HIV-1 to 
chemokine receptors on the host cell, such as CCR5 or CXCR4. This activates the 
gp41 protein and promotes the fusion of the HIV outer membrane with the host cell, 
thereby permitting viral entry and infection.  
 
1.2.1 Role of Protein Dynamics in Cell Signaling 
An important process where protein dynamics plays an especially significant role is in 
cell signaling[10,11]. Cell signaling involves specific recognition sites and strict 
regulation of participating proteins to coordinate molecular interactions at intra- 
and/or inter-pathway levels, ultimately resulting in combinatorial functional diversity. 
The dynamics of vital signaling proteins, such as calmodulin, p53, BRCA1 and 
MAP2, and their functional significance have been investigated[10,11,13-15]. Many 
of these proteins partake in local internal motion via intrinsically disordered residues 
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that facilitate multiple molecular recognition mechanisms, interactions and 
regulation[13-15]. 
 
1.3 Intrinsic Protein Disorder 
Previous examples in Section 1.2 illustrate the functional role of protein dynamics in 
protein segments or regions with stable, localized structures. Conventional ideas, 
based on the “lock-and-key” model, highlighted the functional importance of stable, 
localized structures. However, there has been increasing evidence that non-globular 
domains with unstable and flexible structures, termed intrinsically (or natively) 
disordered proteins or protein regions, are also important for function[9,16,17]. 
Intrinsically disordered proteins lead to poor protein expression and therefore pose 
difficulties in protein purification and crystallization, hindering high throughput 
structural determination[18].  
Functional sites, mainly short linear motifs such as sorting signals, targeting signals, 
protein ligands and post-translational modification sites, have been observed in 
intrinsically disordered proteins and regions[18]. To date, many intrinsically 
disordered proteins and protein regions have been reported[19,20]. These proteins and 
regions have been discovered to be either completely or largely disordered, becoming 
structured only in their bound states (e.g. CREB-CBP complex [21]) or in the 
presence of changes in the biochemical environment [19,20]. Intrinsically disordered 
proteins and protein regions have been reported to engage multiple binding partners 





1.3.1 Role of Intrinsic Protein Disorder in Cell Signaling 
In the context of cell signaling, intrinsically disordered proteins and regions have been 
associated with many regulatory events. Intrinsic protein disorder confers various 
functional advantages, which include the capability to i) accommodate more 
interaction partners and modification sites, ii) provide flexibility in regulation with 
multiple, relatively low affinity linear interaction sites, iii) provide regulation 
specificity with fewer linear motif types and iv) provide large intermolecular 
interfaces with smaller protein, genome and cell sizes[25].  
For example, the recognition of DNA by disordered peptides has been shown to be 
involved in the regulation of gene expression by transcription, epigenetic 
modifications and gene silencing[26].  
 
1.3.2 Identification of intrinsic protein disorder 
Intrinsically disordered proteins and protein regions can be indirectly observed 
experimentally, using X-ray crystallography, Nuclear Magnetic Resonance (NMR-), 
Raman-, Circular Dichroism (CD-) spectroscopy and hydrodynamic 
measurements[18]. These laboratory methods recognize different types of protein 
disorder, giving rise to various definitions of intrinsic protein disorder, such as highly 
flexible regions, regions lacking a secondary structure or regions lacking a well-
defined tertiary structure[18,27].  
Experimental methods for detecting intrinsic protein disorder are often hampered by 
the lack of stable protein structures[27]. To overcome this limitation, various 
computational tools have been developed for the prediction of intrinsically disordered 





1.3.2.1 Computational Tools for Intrinsic Protein Disorder 
Prediction 
Various definitions have been used to describe intrinsically disordered protein 
regions[18]. Consequently, computational tools designed for the prediction of 
intrinsic protein disorder utilize different approaches, based on different operational 
definitions of intrinsic protein disorder[18]. They can be broadly classified into ab-
initio approaches, template-based approaches and meta approaches[28].  
 
1.3.2.1.1 Ab-Initio Approaches 
Ab-initio approaches utilize only sequence-derived information for disorder 
prediction. They originated from early methods that detect low-complexity regions in 
protein sequences, such as SEG[9],[29]. Wootton’s study on compositionally biased 
regions in sequence databases illustrated the association between these regions and 
non-globular domains[9]. However, these methods have been shown to produce 
copious false hits, since the correlation between disordered regions and low sequence 
complexity does not always hold true. More refined methods have since been 
designed[30].  
The earliest prediction system developed specifically for intrinsic protein disorder 
prediction was the suite of PONDR® (Predictor Of Natural Disordered Regions) 
neural network predictors, which identify intrinsically disordered regions based on 
properties such as local amino acid composition, flexibility, hydropathy and 
coordination number[31]. Subsequent examples include the FoldIndex software, in 
which prediction is based on the average residue hydrophobicity and net charge[32]. 
IUPred is another tool in which intrinsic protein disorder is predicted through 
7 
 
estimates of the capability of amino acid residues to form stable, favourable contacts 
based on pair-wise energy content[33]. IUPred adopted the underlying assumption 
that in contrast to globular proteins, intrinsically disordered proteins are not capable 
of forming a large number of stable, favourable interactions[33].  
Some ab-initio methods derive secondary and/or tertiary structure information from 
input protein sequences to check for the presence of loops or coils, which are 
considered to be non-regular secondary structures. For example, GlobPlot[34] 
calculates Russell/Linding propensities for input amino acid residues to be in regular 
secondary structures (α -helices or ß-strands) and non-regular secondary structures, 
defined by the Definition of Secondary Structure of Proteins (DSSP)[35], 
respectively. On the other hand, DISOPRED2[36] and the DisEMBL REMARK465 
predictors were trained on Protein Data Bank (PDB)[37] structural data[18] to 
identify amino acid residues present in the sequence but missing in X-ray structures. 
DisEMBL also predicts protein disorder by detecting “hot loops”, utilizing both 
secondary and tertiary structure information derived from input sequences[18]. The 
algorithm detects highly dynamic DSSP-defined loops/coils with high β-factors (C-α 
temperature factors), according to the training set of PDB[37] structure data[18]. 
 
1.3.2.1.2 Template-based Approaches 
Template-based approaches perform comparisons of input data with similar sequence 
or structure data to determine intrinsic protein disorder.  For example, PrDOS[38] 
performs PSI-BLAST searches of query protein sequences against structural datasets 
of homologous proteins to predict intrinsically disordered residues, in addition to its 
support vector machine (SVM) algorithm trained on position-specific scoring 
matrices (PSSM). DISOclust[39] performs template-based prediction by first 
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determining the per-residue error of the input protein sequence in multiple protein 
fold recognition models, built from homologous templates, followed by analysis of 
the conservation of per-residue error across these models. 
 
1.3.2.1.3 Meta Approaches 
Meta approaches are tools, termed meta-predictors, which combine the prediction 
results of multiple prediction methods. The availability of primary intrinsic protein 
disorder prediction tools has sparked increased research interest in meta-predictors, 
which have demonstrated higher prediction accuracies than primary predictors.  
An example of a meta-prediction system is Meta-Disorder (MD) predictor, which 
integrates prediction results from orthogonal sources of information and explicit 
predictions of secondary structure, solvent accessibility and other sequence properties, 
as inputs to neural networks for model training[40]. Subsequently, MD selects the 
optimum algorithm for disorder prediction[40]. GeneSilico Disorder MD2 is another 
example of a high performance meta-predictor[41]. The genetic algorithm-based 
system first combines and weighs the results of 15 primary predictors, based on 
accuracy. Subsequently, it collects the best alignments from the 8-fold recognition 
method and infers protein disorder from alignment gaps. Other meta-predictors 
reported in the literature include metaPrDOS[42] and PONDR-FIT[43]. In support of 
meta-prediction efforts, a metaserver, MeDor[44], has also been developed to 





1.3.2.2 Benchmark Datasets for Intrinsic Protein Disorder 
Prediction 
To provide further impetus for intrinsic protein disorder prediction, since 2002, the 
worldwide Critical Assessment of Techniques for Protein Structure Prediction 
(CASP) experiments introduced a new category for protein disorder prediction, using 
blind benchmark datasets[45].  
Intrinsic protein disorder prediction has also been facilitated by the availability of the 
Database of Protein Disorder (DisProt) since 2005[46]. DisProt is a specialized 
database containing sequences across multiple species annotated with experimentally 
verified intrinsically disordered regions[46]. 
 
1.3.3 Functional Conservation of Intrinsic Protein Disorder 
The functional importance of intrinsically disordered proteins and protein regions 
raises the likelihood that intrinsically disordered protein residues are evolutionarily 
conserved. This proposal is in line with studies demonstrating that protein dynamics 
properties, such as protein backbone flexibility, protein side-chain dynamics and 
protein vibrational dynamics, are conserved[47-50].  
Conservation of protein disorder has been studied by Chen et al. who demonstrated 
that intrinsically disordered regions are conserved in protein domains and 
families[51]. Reports have also shown that evolutionary conservation and 
maintenance of protein disorder is costly and therefore non-trivial and non-random, 





In the context of cell signaling, the evidence outlined in previous sections implies that 
cell signaling proteins generally possess varying degrees of protein 
dynamics[10,11,22]. These dynamics modulate changes in binding affinity and 
specificity, which is in turn responsible for generating downstream functional 
diversity in signaling pathways. In addition, dynamic properties of proteins have been 
found to be encoded in their primary sequences and conserved in protein domains and 
families [10,29]. Nevertheless, to date, in-depth analysis on the correlation between 
conservation of dynamic properties and sequence and functional conservation is 
lacking in literature. In view of the importance of intrinsically disordered protein 
regions in cell signaling, it is hypothesized that a case study on an exemplar cell 
signaling protein homologous sequence family will bring useful insights to the 
relationship between conservation of dynamic properties and sequence conservation. 
For this project, I have selected the Nuclear Factor Kappa-light-chain-enhancer of 
Activated B cells (NFκB/Rel), a transcription factor protein family important for a 
variety of processes including cell survival, inflammation and immunity[55-57]. This 
project is part of a larger study exploring the function and role of NFκB in cell 
signaling and immunity. 
2 Literature Review 
 
2.1 Transcription Factors 
Transcription factors are a group of cell signaling proteins primarily involved in 
transcriptional regulation, one of the key events of cell signaling responsible for gene 
regulation and downstream protein expression[57]. These proteins play a pivotal role 
11 
 
as ‘central signaling hubs’ that carry and control the flow of information in biological 
pathways from receptors to DNA[13]. Transcription factors regulate a variety of 
diverse cellular and organismal processes[57]. Their high binding specificities, 
coupled with tight regulation, have enabled transcription factors to process a huge 
diversity of signal information with remarkable precision[57]. To date, the intricate 
mechanisms of transcriptional regulation machinery have not been fully elucidated.   
 
2.2 The NFkB Transcription Factor Family 
The NFκB (Nuclear Factor Kappa-light-chain-enhancer of activated B cells) or Rel 
protein family consists of a group of ubiquitously expressed, highly inducible and 
structurally-related eukaryotic transcription factors[58]. They are involved in a large 
variety of cellular and organismal processes, including the cellular stress response, 
cell proliferation and survival, apoptosis, inflammation and innate and adaptive 
immunity[55-57,59-61]. All NFκB transcription factors are related by a highly 
conserved NH2-terminal Rel homology (RH) domain, responsible for DNA binding 
and dimerization[58]. These proteins can be divided into two functionally distinct 
classes that are capable of heterodimerizing freely, based on their C-terminus 
sequence[58].  
There are five mammalian NFκB proteins: NFκB1(p50/p105), NFκB2 p52/p100), 
RelA(p65), RelB and c-Rel[59. The Class I proteins, including NFκB1 (p50/p105), 
NFκB2 (p52/p100) and Drosophila Relish, contain a number of ankyrin repeats with 
trans-repression activity at their C-terminus[59]. Class I proteins possess strong DNA 
binding activity but weak transcriptional activation potential and are generally not 
activators of transcription, except when they form heterodimers with Class II 
proteins[59. The Class II (Rel) proteins, including  RelA(p65), RelB, c-Rel, v-Rel and 
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the Drosophila Dorsal and Dif proteins, in contrast, exhibit weak DNA binding 
activity and are observed to contain a potent trans-activation domain at their C-
terminus[59].  
 
2.2.1 Mechanisms of Action of NFκB  
NFκB proteins associate into homo- and hetero-dimers that bind to target 9-10 DNA 
base pair κB sites[59. The p50-RelA heterodimer represents the prototypical NFκB 
complex and is the major NFκB complex found in most cells. The subunit 
composition of the NFκB complex affects its DNA binding site specificity, 
subcellular localization, trans-activation potential and mode of regulation, therefore 
leading to combinatorial diversity of the downstream responses[58,62,63]. 
NFκB complexes are regulated via several pathways that control its translocation 
from the cytoplasm to the nucleus, in response to extracellular stimuli[61,64]. To date, 
at least three major signaling pathways have been identified: the IκB kinase (IKK)-
dependent canonical pathway, the IKK-dependent non-canonical pathway, and the 
IKK-independent p38-CK2 pathway[61,64]. The IKK-dependent canonical pathway 
involves the regulation of NFκB dimers containing RelA or c-Rel, through association 
with a family of inhibitors known as IκBs (inhibitors of κB), which includes p100, 
p105, IκBα, IκBβ, IκBγ, IκBε, IκBΖ, Bcl-3 and the Drosophilia Cactus protein[65]. 
IκBs typically inhibit the interaction of NFκB with DNA by blocking the DNA 
binding sites of NFκB transcription factors[65]. IκB-NFκB interactions are, in turn, 
mediated by the IκB kinase (IKK), a complex composed of the catalytic IKKα and 
IKKβ subunits, and a regulatory subunit known as IKKγ or NEMO[61,64].  The IKK 
complex, upon activation, phosphorylates two specific serine residues located at the 
NH2-regulatory domain of IκB, leading to IκB ubiquitination and proteosome-
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mediated degradation[61,64]. NFκB dimers containing RelB and NFκB2 (p52/p100) 
are activated through the IKK-dependent non-canonical pathway, where homodimeric 
IKKα lacking the IKKγ (NEMO) subunit phosphorylates the C-terminal region of 
p100[61,64]. This leads to the ubiquitination and degradation of the p100 IκB-like C-
terminal sequences, which in turn releases and activates p52-RelB[61,64].   
The IKK-independent p38-CK2 pathway is activated by UV and the hepatitis B virus 
trans-acting factor PX. Upon UV stimulation, IκBα proteins have been found to be 
phosphorylated by CK2, leading to ubiquitination and degradation[61,64].   
Recent evidence has also suggested that regulation of the NFκB pathway may involve 
other processes such as ubiquitination, acetylation, prolyl isomerization (in the case of 
RelA and p50), as well as phosphorylation (in the case of c-Rel and RelA)[58,61,66]. 
Activation of the NFκB complex results in its export from the cytoplasm to the 
nucleus. This is mediated by specific nuclear-importing signals present in the Rel 
homology domain, which binds to κB sites in the regulatory regions of inducible 
promoters for the activation of targeted gene expression[58,61,66]. Similar to other 
rapid-acting primary transcription factors, such as STATs (signal transducer and 
transcription factors), nuclear hormone receptors and c-Jun, NFκB transcription 
factors can induce rapid changes in gene expression without the need for new protein 
synthesis[58,61,66].  Promoter-bound NFκB activates target gene expression via the 
assembly of enhanceosomes – large nucleoprotein complexes resulting from the 
cooperative binding of regulatory elements, such as chromatin-remodeling proteins, 




2.2.2 NFκB in Human Diseases 
NFκB transcription factors are involved in the upregulation of a variety of genes, 
some of which are responsible for cell proliferation and cell survival[58,60]. Aberrant 
inactivation of NFκB leads to increased susceptibility to apoptosis[60]. On the other 
hand, aberrant activation of NFκB has frequently been observed in cancers, where it 
stimulates the expression of gene clusters, including oncogenes, that promote cell 
survival, inflammation, angiogenesis, tumor development, progression and 
metastasis[67,68].  
Activation of NFκB in cancer cells has been attributed to chronic stimulation of the 
IKK pathway, as well as mutations in NFκB genes or its regulatory genes such as 
IκB[67,68]. Potential cross-talk between IKK/NFκB and other major signaling 
pathways, including the mitogen-activated protein kinase (MAPK), JAK/STAT (Janus 
kinase/signal transducer and transcription factor), p53 and phosphatidylionsitol 3-
kinase (PI3K) pathways, which have been implicated in cancer, have also been 
observed[67,68]. The involvement of NFκB-related pathways in cancers has led to 
investigation of its use as potential biomarkers, as well as therapeutic targets[69,70]. 
In addition, NFκB proteins play an important role in both the innate and adaptive 
immune response, by serving as a regulator of a variety of processes. This includes T-
cell development, maturation and proliferation upon activation of T-cell receptors, B-
cell development, survival, division and immunoglobulin expression, control of the 
immune response and malignant transformation[56,60,71-75]. NFκB transcription 
factors perform various immune-related regulatory activities and function via the 
differential activation of NFκB complexes in response to a diverse spectrum of 
signals[56,60,71-75]. These signals are propagated from receptors including the 
antigen receptors, pattern-recognition receptors and receptors for members of TNF 
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and IL-1 cytokine families[56,60,71-75]. Consequently, misregulation of NFκB 
signaling machinery in the immune system has been associated with 
immunodeficiency and inflammatory diseases[56,57,74]. Constitutive activation of 
NFκB has been frequently observed in asthma, arthritis, renal inflammatory disease, 
sepsis and many other diseases[56,57,74,76]. 
 
2.3 Computational analysis of NFκB proteins  
Findings discussed in the previous sections were primarily gathered from experiments 
using conventional laboratory techniques. To complement laboratory approaches, 
computational approaches have also been utilized for experiments on NFκB proteins. 
In silico methods, driven by technological advances leading to sophisticated 
algorithms and the availability of experimental datasets, have sped up the acquisition 
of meaningful information on NFκB proteins. 
 
2.3.1 Systems analysis of NFκB signaling machinery 
Systems biology, as an emerging field emphasizing “integrative” rather than 
“reductionist” approaches, involves the inter-disciplinary study of interactions, 
functions and behaviours of multi-component biological systems[77,78]. In this field, 
complex data is integrated from various experimental platforms[77,78]. The field of 
systems biology arises from the availability of large datasets from high throughput 
microarray and genomic platforms, as well as advances in computational techniques, 
which facilitate large-scale analysis of biological mechanisms, pathways and 
networks[77,78]. To this end, computational biology has been identified as one of the 
fundamental cornerstones of systems biology for the processing, interpretation and 
manipulation of complex, large-scale multi-experimental datasets[77,78]. 
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In the specific context of NFκB proteins, integrative systems biology approaches have 
been used to identify and study their roles, as well as their downstream target genes, 
in cellular pathways and networks[72,79-81]. These approaches yield useful insights 
on the functions of NFκB proteins by utilizing tools, including computational 
predictions, gene expression profiling, functional annotation from biological 
databases and transcription factor binding site analysis, combined with experimental 
validation via RNAi knockdown or other experiments[72,79-81]. 
Systems biology approaches complement conventional laboratory approaches for the 
investigation of interactions between critical modules or components in cellular 
pathways and networks. It has been established that genes and proteins do not 
function in isolation, instead engaging in complex dynamic interactions to perform 
their biological roles and functions[78,]. These interactions are in turn regulated by 
mechanisms involving transcription factors, signaling pathways and networks. Whilst 
conventional laboratory research has been instrumental for the identification of genes 
and proteins critical for cellular processes such as NFκB transcriptional regulation, 
systems biology approaches attempt to integrate data from various experimental 
sources to obtain an all-encompassing view of how biological systems function as a 
whole[72,79-81]. As the field of systems biology continues to grow and mature, more 
exciting applications of large-scale, integrative approaches will contribute to and 
reshape the landscape of knowledge discovery in NFκB research. 
 
2.3.2 Sequence Analysis of NFκB 
Besides research at the systems-level, large scale promoter sequence studies of NFκB 
binding sites has also been conducted. Such experiments aim to identify and 
characterize conserved NFκB binding sites within sets of gene promoters[83,84]. 
17 
 
These computational analysis efforts have in turn led to the development of 
transcription factor databases and sophisticated prediction algorithms for the 
prediction of transcription factor binding sites (including κB sites)[85-88]. These have 
proved useful in predicting the involvement of NFκB and its downstream target genes 
in various biological pathways.  
On-going bioinformatics sequence analyses, employing comparative genomics and 
laboratory functional studies, have led to the identification of NFκB/Rel homologues 
in various organisms since its discovery by Sen and Baltimore in 1986. To date, 
functionally conserved homologues of mammalian NFκB have been identified in a 
variety of simpler organisms, including Drosophilia melanogaster (fruit fly)[71,89], 
Aedes aegypti (yellow fever mosquito)[90], Aedes gambiae (malaria vector)[90], 
Pinctada fucata (pearl oyster)[91], Litopenaeus vannamei (pacific white 
shrimp)[92,93], Cnidarians (sea anemones and corals)[94] and Porifera 
(sponges)[59].   
 
2.3.2.1 Structural Analysis of NFκB 
Complementary to sequence analysis, structural analyses of NFκB proteins have also 
been conducted via computational means. Following 3D structural determination of 
NFκB complexes bound to DNA, experimental efforts have been channelled towards 
elucidating the detailed binding mechanisms of NFκB complexes in relation to their 
corresponding 3D structures [95-97]. Additionally, computational approaches 
employing molecular modeling and simulations for the study of NFκB inhibitors[98], 
κB DNA sites[99] and the evolution of DNA-binding and protein dimerization 




2.4 Protein Dynamics Analysis of NFκB 
To date, only one protein dynamics study mentioning NFκB proteins is present in the 
literature. The authors simulated the interaction between C-Rel and a 20-bp DNA 
sequence and observed a unique and dynamic NFκB recognition site. The study was 
focused on the dynamics of the DNA, rather than the dynamics of the C-Rel protein 
during binding[99]. However, the effects of protein dynamics in cell signaling and 
allosteric control have been studied and reviewed in general[10,11,15,48-50] 
. 
2.4.1 Intrinsic Protein Disorder Analysis of NFκB 
No intrinsic protein disorder analysis focusing solely on NFκB has been recorded in 
literature. Nevertheless, general research efforts using intrinsic protein disorder to 
identify protein binding sites[101,102] and analyse the functions of chromatin 
remodeling proteins have been recorded[22]. In the context of cell signaling, the 
functional roles of intrinsic protein disorder in cytoplasmic signaling domains[22] and 
in scaffold proteins, which integrate cell signaling pathways[15], have been reported. 
The most relevant study of intrinsic protein disorder in transcription factors was 
conducted by Wells et al., who analyzed p53’s intrinsically disordered N-terminal 
trans-activation domain (TAD) using NMR spectroscopy and X-Ray studies[14].  
 
2.5 Limitations of reported studies 
Based on the literature review, there appears to be limited research on the effects of 
dynamic regions, or more specifically, intrinsically disordered protein regions, on the 
function of NFκB transcription factors.  
Furthermore, general research efforts on NFκB are mostly focused on specific classes, 
types or states of NFκB proteins. Thus, they seem to provide only isolated, contextual 
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views of the NFκB signaling machinery. Clearly, a general macroscopic overview of 
the functional role of protein dynamics in NFκB proteins, across all known subclasses 
and organisms, is lacking. 
 
2.6 Research Aims and Objectives 
In Section 1.4, I have proposed the hypothesis that dynamic properties of proteins, 
particularly cell signaling proteins, may contribute to their function and thus may be 
evolutionary conserved. For this thesis, using NFκB transcription factors as an 
exemplar, my research aim was to computationally analyse the conservation of 
protein dynamics in this protein family and the functional effects that result. In 
Section 1.1, it was highlighted that protein dynamics typically occur at two levels – 
movements of intrinsically disordered protein regions, as well as local internal and 
global external motion occurring at larger amplitudes[7,9]. The primary focus of my 
research was on protein dynamics occurring in intrinsically disordered protein 
regions. 
To systematically achieve my research aim, firstly, there was a need for the 
development of an in silico tool for large-scale identification of intrinsically 
disordered residues. Next, NFκB sequence and structure data had to be collected and 
stored in an online database. Subsequently, residues predicted to be disordered in 
NFκB protein sequences would be subjected to analyses of their conservation, 
localization on 3D protein structures and potential biological functions. 
Specific objectives have been laid out for each phase of the research project, as 
follows: 
- To develop an efficient system for large-scale identification of intrinsically 
disordered regions in proteins. 
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- To collect high quality NFκB sequence and structure data 
- To develop a specialized database of NFκB protein sequences and structures 
for the benefit of the research community 
- To implement the developed prediction system and relevant analysis tools to 
analyse the conservation and functional roles of intrinsically disordered 
protein residues in NFκB signaling machinery. 
 
For my research project, an in silico approach was adopted since large-scale data 
mining and analysis was an integral part of the project. In silico approaches speed up 
these procedures to promote knowledge discovery and provide useful leads for 
experimental validation. 
The methodology and findings, discussed in the next chapters, will lay the foundation 
for further research in the field of protein dynamics, as well as transcriptional 
regulation and cell signaling, potentially leading to significant contributions to 
research in cell signaling. 
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3 DisBatch: A Faster Meta-Prediction 
System for Large-Scale Identification 




The identification of intrinsically disordered protein regions facilitates high 
throughput structural determination, since these relatively unstructured and flexible 
regions are reported to hamper protein purification and crystallization[34]. 
Additionally, intrinsically disordered regions have been known to be important for 
protein function, through roles such as the presentation of protein modification sites 
and the modulation of flexibility and specificity in protein-protein interactions[26]. 
Evidence has shown the evolutionary conservation and maintenance of protein 
disorder to be non-trivial and non-random, suggesting functional significance[26,52-
54]. 
Recently, computational methods, based on various sequence and structural features 
in intrinsically disordered regions, have played an increasing role in the identification 
of intrinsic protein disorder. In particular, meta-predictors that combine the results of 
multiple primary prediction methods have been extensively applied due to higher 
prediction accuracies[38]. Nevertheless, most meta-predictors reported are limited in 
terms of availability and scalability. Many are slow, unavailable locally and impose 
practical restrictions on the number of submissions by users, posing difficulties for 
large-scale batch sequence predictions. For example, GeneSilico MetaDisorder 
MD2[41], the best disorder prediction method in CASP8 & CASP9[45], utilizes 15 
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primary disorder predictors and takes an average of 3 days for the prediction of 1-5 
protein sequences, with a limitation of 10 jobs per day. Furthermore, the software is 
also not available for local use. These constraints greatly limit the ability of the 
scientific community to perform large scale protein disorder analysis. 
In view of these limitations, I have developed a lightweight disorder meta-predictor 
designed for rapid fully automated large-scale disorder analysis from protein 
sequences. The prediction system, named DisBatch (available at 
http://bioslax01.bic.nus.edu.sg/meta/), demonstrates comparable performance with 
GeneSilico MetaDisorder MD2, but with more than 10x speedup. The DisBatch meta-
predictor is now available both as a web service and as a local software package. 
 
3.2 Materials and Methods 
3.2.1 Server Infrastructure 
DisBatch was written using a combination of Bash, Perl and R scripts. The meta-
prediction software was developed and hosted in the BioSlax 7.5 live operating 
system (http://www.bioslax.com), developed by the Bioinformatics Centre in the 
National University of Singapore (NUS), based on the Slax (http://www.slax.org) 
Slackware Linux base distribution. BioSlax contains a suite of bioinformatics tools 
(known as modules), which can be booted from any PC using the computer’s 
memory. The operating system also allows for easy addition of new modules 
containing additional software, services and settings, which can similarly be loaded 
and activated upon boot-up. The BioSlax server running DisBatch consists of a front-
end web portal and a Cloud-based backend. The Cloud backend server runs the 




3.2.2 Primary Disorder Predictor Selection 
Primary disorder predictors were first selected based on their availability and 
scalability. Chosen predictors were required to allow for either i) software download 
for local use, or ii) if used remotely as a web service, unrestricted number of 
submissions by each user per day. Selected predictors include i) DisEMBL 
REMARK465[18], ii) FoldIndex[32] and iii) PrDOS[38]. Information on these 
disorder predictors were discussed previously in Section 1.3.2.1.  
 
3.2.3 Meta-predictor Development 
The performance of each primary predictor was evaluated against Release 5.7 of the 
DisProt dataset[46], which contains sequences annotated with experimentally verified 
intrinsically disordered regions, to determine the optimum threshold with the highest 
accuracy. The DisProt testing set was checked for the presence of NFκB records and 
none were observed. 5 candidate meta-predictors were built from each possible 
combination of primary predictors at their optimum thresholds where the accuracy is 
highest. 
Both DisEMBL REMARK 465[18] and PrDOS[38] predictors convert their results to 
probability scores, therefore their outputs were combined by averaging or weighted 
averaging. Weights for the meta-predictor integrating DisEMBL REMARK 465[18]  
and PrDOS[38] were assigned according to the Matthews correlation coefficient 
(MCC) values[103]. Accuracy values were not used for weighting since both tools 
yield almost equal accuracy at their optimum thresholds. 
FoldIndex[32] rearranged Uversky et al.’s fold boundary equation to calculate the 
prediction score. In his study, the default window size of 51 was used for disorder 
prediction[32]. According to the modified equation, positive FoldIndex[32] scores 
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indicate probable folded proteins or regions and negative FoldIndex scores indicate 
likely disordered proteins or regions. Since FoldIndex[32] does not yield probability 
scores, the original scores were converted to binary values at each position. Positive 
FoldIndex[32] scores representing predicted folded residues were assigned a value of 
0, while negative scores representing predicted disordered residues were assigned a 
score of 1. Due to the difference in scoring system, the probability scores returned 
from DisEMBL REMARK 465[18] and/or PrDOS[38] were combined with the 
FoldIndex[32] output by simple addition for all relevant meta-predictors.  
The optimum threshold of each meta-predictor yielding the highest accuracy was 
determined. The best performing meta-predictor is the combination of FoldIndex[32] 
and PrDOS[38], at the threshold of 1.5, with positive prediction by both tools 
(FoldIndex[32] binary score of 1 and PrDOS[38] probability cutoff score of ≥ 0.5 for 
predicted intrinsically disordered residues). 
 
3.2.4 Performance Evaluation 
Due to low prediction speed and submission restrictions on the MD2 server, only 286 
out of 638 sequences from the DisProt[46] dataset were predicted successfully over a 
period of 2 months. For fair comparison, the performance of each predictor was 
compared against Gene Silico MetaDisorder MD2[41], the best disorder prediction 




3.2.5 Performance Measures 
Performance measures used were sensitivity (SE), specificity (SP), accuracy (ACC), 
positive predictive value (PPV) and negative predictive value (NPV). These were 
calculated based on the number of true positives (TP), true negatives (TN), false 
positives (FP) and false negatives (FN). TP and TN denote the number of known 
disordered amino acid residues and ordered residues predicted correctly, respectively. 
FP represents ordered residues predicted to be disordered, while FN represents known 
disordered residues predicted to be ordered. 
SE = TP/(TP+FN), SP = TN/(TN+FP) represent the proportion of correctly predicted 
disordered amino acid residues and ordered residues in each protein sequence 
respectively. ACC = (TP+TN)/N, where N represents the total number of residues in 
each protein sequence, is a measure of the proportion of all correctly predicted 
residues (disordered and ordered) in each protein sequence. PPV = TP/(TP+FP) 
indicates the proportion of positively predicted residues (TP + FP) that are correctly 
predicted as disordered (TP), while NPV = TN/(TN+FN) indicates the proportion of 
negatively predicted residues (TN + FN) that are correctly predicted as ordered (TN). 
MCC measures the randomness of the prediction and is calculated as: 
 
 
The MCC value ranges between -1 and 1: MCC = 1 for 100% agreement of the 
prediction, MCC = 0 for completely random prediction and MCC = -1 for 100% 
disagreement of the prediction. SE, SP, ACC, PPV, NPV and MCC for each sequence 




3.2.6 Web Interface 
A Web interface was set up to facilitate online access to DisBatch (FoldIndex[32] + 
PrDOS[38]) at http://bioslax01.bic.nus.edu.sg/meta. DisBatch accepts sequences in 
FASTA format as input. Unix, Perl and R commands used in DisBatch are called 
remotely from CGI scripts written in Bash, which in turn submit and retrieve 
predictions from the FoldIndex and PrDOS servers. Due to limitations in 
computational resources, a maximum of 50 sequences is allowed per submission. For 
large-scale disorder predictions, users can download the DisBatch software for free.  
 
3.3 Results 
3.3.1 Predictive Performance 
I have successfully developed DisBatch, a light-weight meta-predictor optimized 
using two primary predictors – FoldIndex[32] and PrDOS[38], to automate large-
scale batch disorder predictions. DisBatch combines the prediction output of 
FoldIndex[32] and PrDOS[38] by simple addition.  
DisBatch gives the best accuracy value of 67.79% when the threshold is set to 1.5, 
where there is an agreement of positive prediction from FoldIndex[32] (binary score: 
1) and positive prediction from PrDOS[38] (probability score : ≥ 0.5). DisBatch 
(67.79% accuracy) slightly outperforms all primary and meta-predictors selected and 
tested in this study and is comparable to GeneSilico Metadisorder MD2’s[41] 
accuracy of 69.21% (Table 1 and Figure 2). Standard error estimates in Figure 2 
indicates that the performance improvement of DisBatch may not be significant. 
Nevertheless, DisBatch performs predictions faster (with more than 10x speedup) 
when compared to MD2[41]. The average prediction rate of DisBatch is 10 minutes 
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per sequence (dependant on PrDOS’[38] server load and prediction speed) while the 
average prediction rate of MD2[41] is 3 days per 1-5 sequences.  
 
Table 2. Performance comparison of primary and meta-predictors for disorder prediction at their respective 
optimum thresholds. The predictive performance of MetaDisorder MD2 and P+F (DisBatch) is highlighted in bold. 
Disorder Predictor Threshold Accuracy 
Primary Predictor 
  DisEMBL 0.5 66.04% 
PrDOS 0.6 67.08% 
FoldIndex NA 64.75% 
   Meta-Predictor 
  GeneSilico MD2 NA 69.21% 
P+D  0.5 67.63% 
P+D (MCC-weighted) 0.5 67.69% 
D+F  1.4 66.83% 
P+F (DisBatch) 1.5 67.79% 







Figure 2. A) Bar plot of mean accuracy values of primary and meta disorder predictors at their respective optimum 
thresholds, with standard error estimates. B) Boxplot of accuracy values of primary and meta disorder predictors at 
their respective optimum thresholds. Each boxplot depicts the minimum accuracy value, lower quartile, median, 
upper quartile, maximum accuracy value and any outlier observation(s) for each predictor. The boxplot for 






The DisBatch web interface is intuitive and consists of a simple search page where 
users can input a maximum number of 50 sequences in FASTA format (Figure 3). 
Since the prediction speed of DisBatch is dependent on the server load of PrDOS[38], 
users are able to set a timeout value, in terms of the number of minutes per sequence, 
for time-efficient prediction. If PrDOS[38] results are not fetched after the timeout 
value, DisBatch will only display prediction results from FoldIndex[32] in the output 
page. To further support large-scale analysis, DisBatch recommends users to contact 
PrDOS[38] directly if the server response is slow or the input dataset is large.  
Users can check their prediction status by clicking on the “Check Prediction Status” 
button after submitting their sequences. Upon successful prediction, DisBatch 
generates a number of output files (Figure 4). Firstly, it provides raw prediction 
outputs from FoldIndex[32] and PrDOS[38] in their original format. DisBatch also 
returns its meta-prediction output score (the sum of the FoldIndex[32] binary score 
and the PrDOS[38] probability score) at each residue position in the sequence, in 
comma separated values (CSV) format. Lastly, the summed meta-prediction score of 
DisBatch was converted to the number of votes at each position and formatted as 
CSV. The minimum number of votes is 0 when FoldIndex[32] and PrDOS[38] return 
a positive value and a probability score of less than 0.5, respectively, while the 
maximum number of votes is 2 when both primary predictors agree on a positive 
prediction of a residue being potentially intrinsically disordered. A help page is 
provided, with prominent hyperlinks at the home page and output page, for further 





Figure 3. Sequence submission page of DisBatch. DisBatch is available at http://bioslax01.bic.nus.edu.sg/meta/. 
 
 
Figure 4 Output page of DisBatch. The page provides download links for each output file, and a link to the help 
page at the bottom of the page. 
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The DisBatch web server only accepts a maximum number of 50 sequences per 
submission, to avoid server overload. For larger-scale predictions, DisBatch is 
available as a local Unix package, downloadable from the web interface. Besides the 
installation files, detailed documentation with full installation and usage instructions 




Availability and scalability poses severe limitations for most disorder meta-predictors 
reported in literature, hindering their use in large-scale predictions from protein 
sequences. In this study, it has been demonstrated that a relatively lightweight 
predictor can be utilized for fast, automated, large-scale disorder predictions, with 
comparable performance to highly accurate meta-disorder predictors. This is 
important because quick, accurate predictors promote large-scale protein disorder 
analysis of proteins and their functions. To date, such large-scale studies have not 
been extensively reported in literature, in part due to restrictions set by current high-
performance meta-predictors.  
 
3.4.1 Predictive Performance 
The results indicate that DisBatch produces slightly higher accuracy at its optimum 
threshold, when compared to other primary and meta-predictors examined in this 
study. The advantage of this slightly better predictive performance is significant with 
large input datasets, which DisBatch is designed specifically to cater for. 
Nevertheless, Gene Silico Metadisorder MD2[41] is still recommended for small-
scale disorder predictions, since it yields higher accuracy. The results, however, 
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suggest that the distribution of scores amongst various predictors used in this study 
occurs at a very wide range of accuracy and it is unclear whether low-scoring hits 
correlate across the predictors. 
 
3.4.2 Scoring Algorithm 
Discretisation of FoldIndex scores and the addition of these scores to probability 
scores returned by other primary predictors in DisBatch may have introduced 
problems and artefacts that may affect the accuracy of the meta-predictor. As such, 
the performance of DisBatch may be improved by seeking alternatives to 
discretisation, such as converting the empirical distribution from FoldIndex of a large 
number of sequences into a probability estimate.   
 
3.4.3 Benchmark Model 
The performance of DisBatch was benchmarked against the performance of 
GeneSilico Meta Disorder MD2[41], claimed to be the best disorder prediction 
method in CASP9. Also, GeneSilico Meta Disorder MD2 is available without 
restrictions for large-scale disorder prediction, albeit at a slow speed. Other meta-
predictors considered as benchmark models are not scalable for large-scale prediction 
and thus their predictive performance is not evaluated. For example, PONDR-FIT[43] 
only allows for manual submission through the web page, while metaPrDOS[42] 
restricts submission to less than 10 sequences per hour and recommends PrDOS for 




3.4.4 Testing Dataset 
With regards to the accidental DisProt subset, comprising of 286 sequences, used for 
testing the predictors, it is difficult to guarantee that the sequences in the dataset were 
not used by any of the predictors as part of their training dataset. DisEMBL[18] and 
PrDOS[38] use PDB[37] structural files as the positive and negative training set, 
while FoldIndex[32] mines literature information for the positive training set 
consisting of intrinsically unfolded proteins and data from PDB[37] as the negative 
training set. Since the DisProt[46] dataset was compiled from published experimental 
data, it may overlap with the training set used by the primary predictors selected in 
this study, especially FoldIndex[32].  
In addition, the DisProt testing set may not represent a genomic sample of disordered 
protein sequences. Other possible sources of dataset bias have also been identified in 
this study. Firstly, the representativeness of the accidental DisProt[46] subset has not 
been evaluated to ensure that it has enough quality for performance evaluation 
purposes. Therefore, the subset may be biased in terms of protein length and/or 
protein family and species representation. Similarly, the ratio of ordered and 
disordered residues in the dataset was not determined and therefore the proportion 
may also be biased, hindering objective performance evaluation. 
These problems can possibly be overcome by adopting an iterative approach to curate 
more intrinsically disordered regions in proteins. In addition, performance evaluation 
of disorder predictors can also be conducted on a larger set of data representative of a 




3.4.5 Software Limitation 
One major limitation of meta-predictors like DisBatch is their reliance on remote 
primary prediction server(s). Since both local and online versions of DisBatch use 
PrDOS[38], the speedup of DisBatch is largely dependent on PrDOS'[38] prediction 
speed and this makes DisBatch vulnerable to the idiosyncrasies of PrDOS[38]. 
Similarly, FoldIndex[32] results are retrieved through connection with the FoldIndex 
server, albeit at a significantly faster speed (≈ 3 seconds per sequence on average) 
compared to PrDOS’[38] average of 10 minutes per sequence. 
DisBatch returns results from FoldIndex[32] as an alternative if the PrDOS[38] server 
is facing technical difficulties. Nevertheless, other meta-predictors demonstrated to 
have comparable results with DisBatch in this study. In particular, the DisEMBL[18] 
and FoldIndex[32] (D+F) meta-predictor yields 66.83% accuracy as compared to 
DisBatch’s 67.79%. This meta-predictor can be considered as another alternative. One 
advantage of this alternative is that DisEMBL[18], unlike PrDOS[38], can be 
executed offline without any server connection.  
 
3.5 Future Work 
To address pitfalls pertaining to predictive performance, dataset and software, 
highlighted in Section 3.4, rigorous investigation into the benchmark testing dataset is 
necessary to ensure objective performance evaluation. More in-depth examination of 
the testing dataset, as well as the training datasets of the primary predictors, should be 
carried out in the future to lend support to the performance advantage of DisBatch. 
Future work can include analyses on protein length, protein families and species 
covered in the testing set, as well as the correlation of high and low-scoring hits, and 
the proportion of ordered and disordered residues. Furthermore, blind CASP[105] 
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datasets not present in the training set of all primary predictors can also be used as the 
testing set, to eliminate the problem of dataset bias.   
More importantly, the prediction and scoring algorithm in DisBatch can be improved 
to yield higher accuracy. As discussed, the scoring algorithm can be revised to include 
only probability scores. On the other hand, innovative prediction algorithms can be 
explored and incorporated into DisBatch. 
Future improvements to the DisBatch web service are also necessary to improve 
usability. The speedup of DisBatch compared to other meta-prediction tools available 
can be quantified in terms of initial, transitional and terminal stage. The prediction 
service can be configured to return results by e-mail for greater user convenience. 
Also, interactive visualization and analysis tools such as plots and annotated sequence 
views can be provided by the web server to further facilitate meaningful large-scale 
analysis. 
 
3.6 Chapter Conclusion 
This study addresses the problem of using meta-predictors to predict intrinsically 
disordered protein regions. High-performing meta-predictors like GeneSilico's 
MetaDisorder MD2[41] are slow and pose access limitations. Hence, I propose an 
alternative meta-predictor, DisBatch, which is much faster and has comparable 
performance. DisBatch is available both as a web service and local software. Despite 
the limitations raised in this chapter, the study represents a call for the development of 
large-scale disorder predictors with a more balanced performance-to-time ratio. Such 
powerful predictors will further drive research in intrinsic protein disorder and lend 
crucial applications to the elucidation of the biological functions of intrinsically 




4 NFκB Base : A Specialized Database 
of NFκB Proteins 
 
4.1 Background 
NFκB transcription factors play a critical role in transcriptional activation and are 
associated with a wide range of important cellular processes involving cell 
proliferation and survival and the immune response[65,106-109]. In addition to 
experimental and structural data, protein sequences of NFκB have important research 
value for functional characterization of the protein family[83,90]. Numerous studies 
have been performed with NFκB sequences, as outlined in Section 2.3.2. 
To date, while a large number of NFκB protein sequences can be found in major 
sequence databases, there is no specialized, publicly accessible database specifically 
for NFκB protein sequences, though datasets containing NFκB target genes are 
available online (http://people.bu.edu/gilmore/nf-kb/target/index.html). This presents 
a need for a centralized repository containing an annotated dataset of NFκB protein 
sequences to fill the gap in current resources on NFκB.  
In this chapter, I present NFκB Base, a specialized database of experimentally 
verified, manually curated NFκB protein sequences. The database is integrated with 
analysis tools including (i) dynamic data display, (ii) keyword search and (iii) Basic 
Local Alignment Search Tool (BLAST) sequence search. The main aim of NFκB 
Base is to support and facilitate large-scale sequence and functional studies of NFκB 
proteins. NFκB Base is available at http://bioslax01.bic.nus.edu.sg/nfkb/. 
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4.2 Materials and Methods 
4.2.1 Server Infrastructure 
Similar to DisBatch, NFκB Base was developed and hosted in the BioSlax 7.5 live 
operating system (http://www.bioslax.com), using the Linux-Apache-MySQL-PHP 
(LAMP) software stack. 
 
4.2.2 Sequence Data Collection 
Keyword and sequence similarity searches were performed against NCBI Protein 
(GenBank Flat File Release 177.0, Release Date: April 15, 2010)[110], UniProt [52] 
(Release 2010_06, published May 18, 2010)[111] and PDB (Release date: June 1, 
2010)[37]. Sequence similarity searches were performed using the Basic Local 
Alignment Search Tool (BLAST+) software, version 2.2.23[112]. Literature 
information was also mined from sequence records.  
 
4.2.2.1 Inclusion and Exclusion Criteria 
All information was manually filtered and verified, according to keywords and 
literature, to remove irrelevant and hypothetical records. Duplicates for each record 
were also identified and recorded. The inclusion and exclusion criteria used during the 




Figure 5. Detailed sequence inclusion and exclusion criteria for records in NFκB Base. 
 
4.2.3 Database Design 
Collected and manually reviewed NFκB sequence data was stored in the MySQL 
Relational Database Management System. Each entry is assigned a unique accession 
number, beginning with the NFκB protein type and followed by a unique 5-digit serial 
number. A typical entry contains annotated information, where available on (i) source 
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accession number, (ii) NFκB protein type, (iii) protein name and description, (iv) 
scientific and common name of source organism, (v) gene name, (vi) chromosome 
name, (vii) sequence length, (vii) sequence, (viii) accession number(s) of duplicate 
record(s) and (ix) relevant cross-links to major databases. Cross-references link to the 
NCBI Protein[110], UniProt[111], Gene Ontology (GO)[113], Hugo Gene 
Nomenclature Committee (HGNC)[114], InterPro[115], PDB[37], PubMed[116] and 
the NCBI Taxonomy databases[116], where additional sequence, function, gene 
nomenclature, protein domain and family, structural, literature and taxonomy 
information can be found, respectively. These links are included to further increase 
NFκB information coverage. 
 
4.2.4 Web Interface 
The web interface for NFκB Base was constructed with HyperText Markup Language 
(HTML), PHP, web BLAST, Perl CGI scripts and the jQuery libary. HTML was used 
to present web page content, while PHP was used for database server connection for 
search queries and entry display. The web BLAST Perl CGI was used to perform 
online BLAST searches by calling the local BLAST package and BLAST databases. 
The jQuery library, based on Asynchronous Javascript and XML (AJAX), allows for 
dynamic table browsing and display. It is designed to present a quick and concise 
view of the database, displaying only important fields, including NFκB and source 
accession numbers with relevant hyperlinks to full entry records, organism name and 





4.2.5.1 NFκB Base Content 
The latest release of NFκB Base (Beta 2.0) contains 413 records of experimentally 
verified protein sequences within the eukaryotic NFκB family. There are 22 C-Rel 
records, 41 Dorsal records, 29 Dif records, 70 NFκB1 records, 59 NFκB2 records, 95 
RelA records, 19 RelB records and 71 Relish records (Figure 6). These records were 
collected from major sequence and structure databases, including NCBI Protein[110], 
UniProt[111] and PDB[37], and were subsequently filtered and reviewed manually. 
Each record was assigned a unique accession number containing information on the 
protein type and serial number. In addition, each record is linked to a detailed entry 
page, where all annotated data is organized in fields (Figure 7). 
 
4.2.5.2 Features 
4.2.5.2.1 Keyword Search 
NFκB Base supports keyword search, through the integration of a search query box on 
the top of each page. Users can query the database based on specific fields, including 
NFκB Base accession number, source database accession number, Gene Identifier 
(GI) number[116], protein description, gene name and organism name. For more 
general searches, users can also look up a keyword in all fields of the database. Search 
results are displayed in tabular format, with basic information including NFκB Base 
accession number, source database accession number, organism name and protein 
description (Figure 8). The accession number fields are hyperlinked to the NFκB 
Base entry page and source database entry page. 
Alternatively, users can browse the database dynamically, in the same tabular view as 
the search output page (Figure 9). Users can customize the number of entries to 
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display and perform a keyword search on these fields dynamically. Each displayed 
field can also be sorted dynamically, in ascending or descending order. 
 
 
Figure 6. Number of records present in NFκB Base (Release: Beta 2.0) for each NFκB protein type. NFκB Base is 
available at http://proline.bic.nus.edu.sg/~shenjean/nfkb/. 
 
Figure 7. A typical entry page of NFκB Base. Each entry contains information, where available on source 
accession, NFκB protein type, description, organism, gene name, chromosome name, sequence length, accession 
number(s) of duplicate record(s) and cross-links to major online databases, including NCBI Protein (sequence 
database), UniProt (sequence database), GO (Gene Ontology database), HGNC (gene nomenclature database), 
InterPro (protein domain and family database), PDB (protein structure database), PubMed (literature database) and 





Figure 8. Sample keyword search output of NFκB Base, displaying the accession number, source accession 
number, organism and description fields. NFκB Base supports keyword searches in all or specific fields, where 
users can submit a query at the top of every page, shown in the upper frame of this figure. 
 
 




4.2.5.2.2 Sequence Similarity Search 
Besides keyword searches, NFκB Base also integrates the BLAST[112] tool for 
sequence similarity searches against all or specific types of NFκB proteins (C-Rel, 
Dorsal, Dif, NFκB1, NFκB2, RelA, RelB and Relish) recorded in the database. 
BLAST[112] is a local sequence comparison tool that returns nucleotide or protein 
sequences containing identical or similar regions with the input query sequence. All 
BLAST types, including blastp, blastn, blastx, tblastn and tblastx are supported by 
NFκB Base, allowing easy identification of matching or similar NFκB sequences to 
the query sequence. The BLAST interface provides all standard configurable 
parameters, similar to the original NCBI[116] BLAST interface. 
 
4.2.5.2.3 Batch Download 
NFκB Base provides batch download of all records or records specific to a particular 
NFκB protein type stored in NFκB Base. Users can batch retrieve all annotations in 











NFkB Base represents the first specialised database containing annotated, 
experimentally verified information pertaining to NFκB proteins. High quality data is 
important for research, especially those utilizing computational approaches. With 
increasing data publicly available in general and specialised databases, the laborious 
procedures of data collection and annotation often form the rate-limiting step of data-
centric research.  NFkB Base aims to speed up and facilitate research on NFκB 
transcription factors by providing readily accessible, high quality information on these 
proteins. To further benefit the research community, NFκB Base is also part of the 
BioDB100 initiative (http://biodb100.apbionet.org) aiming to support the 
reproducibility of scientific data through archival and re-instantiation  
 
4.2.7 Future Work 
As the quality of data lies in the core of databases like NFκB Base, future efforts 
entail the compilation of additional information to be integrated in NFκB Base. The 
database can be expanded to include relevant information such as conserved domain 
and functional site data, as well as protein dynamics data such as annotations on either 
experimentally verified or computationally predicted intrinsically protein disorder 
residues. More interactive structure, sequence and phylogeny visualizations and 
analysis tools can also be built into the NFκB Base web interface.  
 
4.2.7.1 Community Annotation Policy 
In addition, to speed up knowledge discovery and sharing, NFκB Base can adopt a 
community annotation policy, similar to Allergen Atlas[117] and T3SEdb[118], 
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where users can submit new curated data and/or update existing NFκB information in 
the database. The inclusion and exclusion criteria outlined in Figure 5 can be used as 
a guide for the community annotation policy. 
 
4.2.8 Chapter Conclusion 
This study describes the development of a specialized database, NFκB Base, 
containing specific annotated information on NFκB proteins, as well as integrated 
analysis tools. The database contributes to research on the NFκB transcription 
regulation machinery, through the sharing of curated information that leads to a better 




5 The Role of Conserved Disordered 
Residues in NFκB Function 
 
5.1 Background 
Contrary to the conventional view that folded, structured proteins are important for 
function, it has been discovered that intrinsically disordered proteins or protein 
regions, which are more flexible than their counterparts, contribute to a variety of 
cellular functions[17]. The functional roles of these proteins or protein regions have 
been studied, particularly in the field of cell signaling[14,15]. They allow for the 
accommodation of multiple interaction partners and modification sites, as well as 
regulation flexibility[18]. Analogous with sequence conservation of functionally 
important sites, the evolutionary conservation of intrinsic protein disorder has been 
discovered to be non-trivial and non-random, further signifying its functional 
importance[26,53,54]. 
Literature review of studies on intrinsic protein disorder, as described in Section 1.3, 
gave rise to my hypothesis that intrinsic protein disorder properties of cell signaling 
proteins are evolutionary conserved in protein families. Details on the formulated 
hypothesis can be found in Section 1.4. 
The hypothesis called for systematic protein sequence and disorder conservation 
analyses on an exemplar cell signaling protein family for validation. To this end, the 
Nuclear Factor Kappa-light-chain-enhancer of Activated B cells (NFκB/Rel) proteins, 
crucial for processes such as cell proliferation, survival, inflammation and 
immunity[55,58], were selected as the exemplar protein family. Currently, no 
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investigation on the functional role of intrinsic protein disorder in NFκB transcription 
factors has been recorded. This study therefore addressed a specific gap in NFκB 
literature. 
In the final phase of my research project, I developed an in silico analysis pipeline for 
the identification of intrinsically disordered protein residues and the analysis of the 
conservation, localization and function of predicted disordered regions. The results of 
the analysis revealed distinctive protein disorder distribution patterns across each 
NFκB protein type, which are conserved across different species. This implies the 
functional contribution of intrinsically disordered protein residues in promoting DNA 
and ankyrin protein binding events. 
 
5.2 Materials and Methods 
5.2.1 Sequence Data Collection 
NFκB protein sequences used for this study were collected from NFκB Base (Chapter 
4), which contains 413 experimentally verified, manually annotated NFκB sequences. 
To minimize redundancy, the collected sequences were further processed to select the 
longest, unique representative sequence for each organism in each NFκB protein type. 
A total of 18 NFκB1 representative sequences across multiple organisms were 
analysed. These 18 sequences comprised 11 NFκB2 sequences, 14 C-Rel sequences, 6 
Dif sequences, 16 Dorsal sequences, 19 RelA sequences, 5 RelB sequences and 24 
RelB sequences. 
 
5.2.2 Multiple Sequence Alignment 
For each NFκB protein type, multiple sequence alignment was performed using 
Multiple Sequence Comparison by Log-Expectation (MUSCLE)[119] hosted on 
49 
 
EUAsiaGrid[120]. The alignments were checked and edited manually for 
misalignments in BioEdit[121]. Positions in the alignments where more than 50% of 
the sequences contained a gap were removed to yield entropy and conservation 
measurements with high statistical support. 
 
5.2.3 Entropy Analysis 
Based on the multiple sequence alignment, the level of amino acid residue 
conservation at each position was inferred using Shannon’s entropy values calculated 
using BioEdit[121]. The entropy value at each position provides a measure of 
uncertainty at each position relative to other positions and is defined as H(x) = -∑f(b, 
x)ln(f(b, x)), where f(b, x) is the frequency at which residue b is found at position 
x[122]. The maximum entropy is calculated as Hmax = ln n = ln 20, where n 
represents the maximum number of variations at a particular position[122]. High 
entropy values correspond to positions in the alignment with high variability and thus 
low residue conservation. 
 
5.2.4 Intrinsic Protein Disorder Analysis 
DisBatch (Version 0.02, Chapter 3) was used to predict potentially disordered 
residues, with the threshold set at 0.5 (for positive prediction by PrDOS[38] only) and 
1.5 (for positive prediction by both PrDOS[38] and FoldIndex[32]). 
 
5.2.5 Conservation of Intrinsic Protein Disorder 
Conservation of intrinsic protein disorder at each residue position in the multiple 
sequence alignment, for each NFκB protein type across multiple species, was 
measured first using the standard deviation (SD), followed by the coefficient of 
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variation (CV). While SD is unit-dependent, CV represents a normalized, scale-
invariant measure of the dispersion of the average disorder score around the mean. 
CV is expressed as the ratio of the standard deviation to the mean: CVx= σ(µx) / µx       
where σ(µx) represents the standard deviation of the mean DisBatch protein disorder 
score, µx, at position x, across all sequences (from multiple orgnanisms) of a specific 
NFκB type in the multiple sequence alignment.  Low CV values correspond to residue 
positions in the alignment where DisBatch protein disorder scores across all 
sequences share low standard deviations in relation to the mean, thereby implying 
conservation of the average disorder scores.    
 
5.2.6 Structural Analysis 
Structural data of NFκB proteins were mined from annotated sequence records and 
extracted from the Protein Data Bank (release date: June 1, 2010)[37]. A total number 
of 35 wild type and mutated protein NFκB structures in bound states from all 
available species were collected and carefully reviewed. Protein sequences from 
structural records were a subset of the NFκB sequence dataset in NFκB Base that are 
used in analysis of intrinsic protein disorder properties. 16 representative, unique 
structures for each NFκB dimer combination in either active or inhibited states were 
selected for further analysis. The NFκB protein structures were superimposed and 
annotated using PyMOL (version 0.99rc6)[123]. Root mean square deviation (RMSD) 
values representing the average distance between superimposed atoms were also 
calculated by PyMoL. β-factors for each atom, indicative of the degree of thermal 






5.3.1 Conserved intrinsic protein disorder signatures in NFκB   
To predict intrinsically disordered residues in both Class I and Class II NFκB 
proteins, DisBatch was used. The average DisBatch score for each position in the 
multiple sequence alignment was calculated and compared with Shannon’s entropy 
values[122] to check for any correlation between intrinsic protein disorder and residue 
conservation.  High entropy values represent positions in the alignment with high 
variability, implying low residue conservation.  
NFκB proteins share a conserved N-terminal Rel homology (RH) domain, which is 
further subdivided into the N-terminal specificity sub-domain and the C-terminal IPT 
sub-domain[58]. The N-terminal specificity (RHD) sub-domain resembles the core 
domain of the transcription factor p53, whereas the C-terminal IPT sub-domain is an 
immunoglobulin like fold containing the interaction site of NFκB with its inhibitor, 
IκB[58]. The RH domain also contains DNA binding sites, ankyrin protein binding 
sites and the dimerization interface[58]. 
As expected, Shannon’s entropy analysis[122] in each NFκB protein type showed 
high residue conservation within the NH2-terminal Rel homology (RH) domain, 
particularly for the DNA and ankyrin protein binding sites, as observed by troughs 
representing lower entropy values in Figure 11 and Figure 12.  Unlike Class II NFκB 
proteins, Class I NFκB proteins contain protein-protein interaction domains including 
ankyrin repeats[124-127] in the ANK domain and the Death domain[128] at the C-
terminal. The ANK domain[124-127] is responsible for mediating protein-protein 
interactions, while the Death domain[128] acts as an adaptor and recruiter in signaling 
pathways [64].  In comparison with the N-terminal RH domain, the ANK and Death 
domains in Class I NFκB proteins appeared to be less conserved according to the 
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Shannon’s entropy values[122]. Nevertheless, there seemed to be no apparent 
correlation between the average disorder score and Shannon’s entropy values, 
suggesting that intrinsic protein disorder is not associated with residue conservation. 
The distribution of the average disorder score in each NFκB protein type (Figure 11 
& Figure 12) showed predicted moderately and highly disordered residues (residues 
with an average disorder score of ≥0.5 and ≥1.5)  to be associated with DNA binding 
sites in the RHD N-terminal specificity structural sub-domain, as well as with the 
ankyrin protein binding sites in the C-terminal IPT structural sub-domain for both 
Class I and Class II NFκB proteins.  
The ANK and Death domains in Class I NFκB proteins (Figure 11) were observed to 
be generally non-disordered. Notably, a prominent spike of average disorder score at 
the N-terminal end of the ANK domain was seen in all Class I proteins, except Relish. 
Interestingly, DNA binding sites in Class I proteins were observed to be more 
disordered, with generally higher average disorder scores than Class II proteins. Some 
DNA binding residues at the C-terminal end of the RHD domain, at approximate 
alignment position 150-200, were predicted to be ordered in most Class I and Class II 
proteins but were absent in RelA, RelB and C-Rel. Furthermore, residues that are part 
of the dimerization interface were found to be generally more disordered in Class I 
proteins (except in NFκB1) and less disordered in Class II proteins. These differences 
in protein disorder patterns between Class I and Class II proteins may shed light on 




Figure 11. Distribution of the average disorder score at each alignment position for Class I NFκB proteins at the 
RHD domain of A) NFκB1, B) NFκB2 and C) Relish, as predicted by DisBatch. The average disorder score 
cutoffs of 0.5 and 1.5 were used to distinguish between moderately (predicted only by PrDOS to be disordered) 
and highly disordered (predicted by both PrDOS and FoldIndex) residues, respectively. Shannon’s entropy values 







Figure 12. Distribution of the average disorder score at each alignment position for Class II NFκB proteins at the 




Figure 13. Distribution of the average disorder score at each alignment position for Class I NFκB proteins at the 




Figure 14. Distribution of the average disorder score at each alignment position for Class II NFκB proteins at the 




Figure 15. Distribution of the average disorder score at each alignment position for Class I NFκB proteins at sites 




Figure 16. Distribution of the average disorder score at each alignment position for Class II NFκB proteins at sites 




Figure 17. Distribution of the average disorder score at each alignment position for Class I NFκB proteins at the 




To further assess the conservation of protein disorder properties in NFκB proteins, I 
measured the standard deviation of the average disorder score, as well as the scale-
invariant coefficient of variation (CV) values at each position. Scatter plots for each 
NFκB protein type were generated to further examine the relationship between the 
average disorder score and the standard deviation and CV of the average disorder 
score (Figure 18-Figure 23). Each point in the scatter plot represents a specific 
alignment position in a particular NFκB protein type. The scatter plots of both the 
standard deviation and CV against the average disorder score generally agree with 
each other (Figure 18-Figure 23). These plots show distinct quadrants, mainly i) 
conserved, non-disordered (residues not predicted to be disordered by DisBatch 
(bottom left of scatter plot) and ii) conserved, disordered (bottom right; Figure 18-
Figure 23).  
In all NFκB protein types, the conserved, non-disordered quadrant comprised some 
ankyrin protein binding sites, IPT domain residues, RHD domain residues and non-
functionally annotated residues. Most ANK and Death domain residues in Class I 
proteins were represented as outliers in the conserved, non-disordered quadrant, while 
DNA binding sites in Class I NFκB  proteins tended to lie in proximity to or within 
the conserved disordered quadrant (Figure 18 & Figure 21). In addition, only 
dimerization interface residues in NFκB2 were observed clearly in both plots to lie 
within the conserved disordered quadrant (Figure 19 & Figure 22), while 
dimerization interface in Class II proteins were generally found in the non-disordered 
quadrants (Figure 19, Figure 20, Figure 22 & Figure 23). Class II NFκB proteins, 
on the other hand, had slightly less DNA binding sites within the conserved 
disordered quadrant and slightly more within the conserved, non-disordered quadrant, 
compared to the Class I proteins (Figure 19, Figure 20, Figure 22 & Figure 23). 
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Interestingly, many DNA binding sites in Dif were found in the non-conserved, 
disordered quadrant (Figure 20 & Figure 23). 
The scatter plot of the average disorder score against the CV of the average disorder 
score indicated a general inverse correlation (Figure 21, Figure 22 & Figure 23). 
The correlation between the 2 variables was not perfect and quantification of the 
correlation using the coefficient of determination (R2) yielded low values of ≤ 0.5. 
This may possibly be an artefact since it is expected for the CV and average disorder 





Figure 18. Scatter plot of average disorder score against the standard deviation of disorder scores for Class I NFκB 
proteins, A) NFκB1, B) NFκB2 and C) Relish, as predicted by DisBatch. The scatter plots show 2 distinct 
quadrants of:  conserved non-disordered residues (bottom left) and conserved disordered residues (bottom right). 




Figure 19. Scatter plot of average disorder score against the standard deviation of disorder scores for Class II 




Figure 20. (Cont’d from Figure 19) Scatter plot of average disorder score against the standard deviation of average 




Figure 21. Scatter plot of average disorder score against the CV of average disorder score for Class I NFκB 
proteins, A) NFκB1, B) NFκB2 and C) Relish, as predicted by DisBatch. The scatter plot shows 4 distinct 
quadrants of:  non-conserved, non-disordered residues (top left of scatter plot), non-conserved disordered residues 
(top right), conserved non-disordered residues (bottom left) and conserved disordered residues (bottom right). 




Figure 22. Scatter plot of average disorder score against the CV of average disorder score for Class II NFκB 




Figure 23. (Cont’d from Figure 22) Scatter plot of average disorder score against the CV of average disorder score 




5.3.2 Structural Analysis 
Following intrinsic protein disorder analysis at the sequence level, an attempt was 
made to map the predicted disordered residues in NFκB proteins to representative 3D 
structural data. The structural analysis was conducted to provide a more in-depth case 
study of NFκB sequence properties and the structures analyzed represented a subset of 
the NFκB protein sequence dataset. 
Prior to this, all available 3D structures in each NFκB protein types were 
superimposed against each other to confirm the representativeness of the selected 
structure sample. All superimposed structures exhibited high structural similarity with 
low root mean square deviation (RMSD) values (data not shown).  
Conserved non-disordered and conserved disordered residues in each NFκB protein 
type were mapped to available PDB[37] structures, according to their respective 
quadrants demarcated in Figure 18 to Figure 23. These annotated structures were 
compared with β-factor values and visualized as heat maps according to the original 
PDB annotation[37]. 
Structural analysis of Class I NFκB homodimers showed most predicted conserved, 
non-disordered residues to surround the DNA at the N-terminal RHD domain and 
most conserved disordered residues to be present at the C-terminal IPT domain 
containing the ankyrin protein binding sites and dimerization interface (Figure 24). 
Only residues in the N-terminal Rel Homology (RH) domain were visible in 3D 
structures, while coordinates of residues occurring in the C-terminal ANK and Death 
domains were not present in the PDB[37] records. 
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Class II homodimers showed more conserved disordered residues surrounding the 
DNA and more conserved, non-disordered residues at the C-terminal IPT domain with 
ankyrin protein binding sites and the dimerization interface (Figure 25).  
In addition, the insert α-helical regions of both Class I and Class II NFκB dimers were 
found to be disordered (Figure 24 & Figure 25). The insert region in Class I proteins 
differed from the Class II proteins in that the former contains an additional α-helix. 
These disordered insert α-helical regions formed grooves in the NFκB proteins that 
resembled potential protein binding sites. In Class I NFkB proteins the clefts formed 
by the insert regions were narrow and deep (Figure 24) whereas in the Class II NFkB 
proteins the clefts formed by the insert regions were much wider and shallower 
(Figure 25). According to literature, the insert regions represent potential interaction 
and/or binding sites[96]. 
NFκB heterodimers are formed between Class I and Class II proteins. As expected, 
heterodimers contain a hybrid of conserved non-disordered and disordered residues in 
all functional sites and domains, suggesting distinct mechanisms and functions 
differing between Class I and Class II homodimers (Figure 26). For the heterodimers, 
the configuration of the conserved disordered and non-disordered residues of their 
component monomers matched with those observed in their respective homodimers. 
Interestingly, inhibited NFκB dimers were largely made of conserved disordered 
residues. In contrast, their inhibitors (IκB) were found to be greatly conserved and 
non-disordered (Figure 27).  
The protein structures annotated with intrinsic protein disorder information were 
compared with their respective β-factor annotation. β-factors are also known as 
temperature factors, which represent the degree of thermal displacement and thus 
flexibility of an atom[37]. Research has associated intrinsically disordered protein 
70 
 
regions with high β-factors[129]. Here, the results showed a general, loose agreement 
between conserved disordered residues and residues with high β-factors, as well as 
conserved non-disordered residues and residues with low β-factors. This is with the 
exception of Class I monomers (NFκB1 and NFκB2) that are part of the heterodimers 
in Figure 26, where residues with high β-factors were found to be conserved and non-
disordered.  
From the observation, the DisBatch predictor appears to be more sensitive towards 
intrinsically disordered regions as compared to annotated β-factors. There is a 
possibly that the predictor may “over-predict” disordered regions, thus operating at 
the lower range of accuracy with false positives. Alternatively, the predictor can 
probably detect regions with some dynamics, but generally evolved – not to have 
intrinsic disorder – but to remain disordered until a binding event occur. In that mode, 
some sequence conservation of these dynamic properties is expected since 
intrinsically disordered proteins exhibit structure-function relationship in the bound 
form. Nevertheless, β-factors are not guaranteed reliable indicators of disorder, since 





Figure 24. Structures of representative Class I NFκB homodimers, NFκB1 (top) and NFκB2 (bottom), coloured 
according to protein disorder annotations (left) and β-factors (right). The C-terminal IPT domain contains ankyrin 
protein binding sites enveloping the dimerization interface. Ankyrin repeats and the Death domain were not 
present in the 3D structures. The α-helical insert regions are conserved disordered residues, highlighted in red, at 
the left of the protein structure in the N-terminal RHD domain. 
 
 
Figure 25. Structures of representative Class II NFκB homodimers, RelA (top) and C-Rel (bottom), coloured 





Figure 26. Structures of representative NFκB heterodimers formed between Class I and Class II NFκB proteins, 
coloured according to protein disorder annotations (left) and β-factors (right). Examples shown here are the RelA-
NFκB1 (top) and RelB-NFκB2 (bottom) heterodimers. 
 
 
Figure 27. Structures of representative RelA homodimer (top) and RelA-NFκB1 heterodimer (bottom) in the IκB 







This study aimed to examine the functional roles of intrinsic protein disorder in the 
exemplar NFκB transcription factors. To this end, I have utilized a suite of 
computational tools to identify and analyze intrinsically disordered protein regions in 
different types of NFκB proteins at both sequence and structural levels. Comparisons 
were made between our findings and well-known measures, including Shannon’s 
entropy values[122] and β-factors[37]. β-factors are well known to correspond to 
crystal quality and R-value in any given crystal structure[37]. 
From both sequence and structural analysis, key differences in terms of protein 
disorder patterns between the Class I and Class II NFκB proteins have been observed. 
Firstly, Class I NFκB proteins were more disordered in the vicinity of the DNA 
contacting sites at the N-terminal RHD domain compared to Class II proteins. This 
may explain their reported stronger DNA binding activity in comparison with Class II 
proteins[58,106]. Protein recognition of DNA target sites represents a crucial event 
for key gene functions, one of which includes transcription. It has been reported that 
protein-DNA interactions proceed via an initial, non-specific binding state which 
accelerates the search for target sites through multiple intramolecular processes, 
including diffusion along the DNA[131,132]. This is facilitated by flexible, dual-role 
residues which act as switches between non-specific and specific binding states 
through conformational changes and rearrangements[131,132]. More specifically, 
Kalodimos et al. observed that the hinge region in the DNA binding domain of the 
lactose repressor is disordered in the free as well as non-specific binding state but 
forms an α-helix in the specific binding state[132].  
Hence, it could be proposed that disordered residues in NFκB proteins function 
similarly in promoting protein-DNA interactions. 
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Secondly, Class I NFκB proteins were more disordered than Class II proteins at their 
dimerization interfaces, suggesting different modes of dimerization. However, there 
seemed to be no substantial literature on the differences in dimerization modes 
between both NFκB protein classes.  
Class I NFκB proteins contain ankyrin repeats in the ANK domain[124-127,133-135] 
and the Death domain[128], not found in Class II proteins. Both domains have been 
discovered to be non-disordered. For Class I proteins, only predicted disordered 
residues occurring in the Rel Homology (RH) domain could be mapped to the 3D 
crystal structure, whereas ankyrin repeats and Death domains occurring in the N-
terminal IPT domain were not found in the structure.  On the other hand, Class II 
NFκB proteins have been reported to possess a potent trans-activation domain at the 
C-terminus[58]. However, sequence-specific positions of the trans-activation domain 
were not found in NFκB records in major databases during the data mining step. 
Therefore, analyses of the presence, sequence localization and/or structural 
localization of the N-terminal IPT and trans-activation domains were not applicable to 
this study. 
From this study, it could be observed that not all functional sites were intrinsically 
disordered. Most ANK[125] and Death domain[128] residues in Class I proteins were 
discovered to be conserved and non-disordered. Some ankyrin protein binding site 
residues in both classes of proteins were conserved and non-disordered, while the rest 
were either non-disordered or disordered in a conserved or non-conserved manner. 
This could also be applied to RHD and IPT domain residues. 
Nonetheless, many functional sites in NFκB proteins have been observed to be 
conserved, both in terms of sequences (from Shannon’s entropy values)[122] and 
intrinsic protein disorder properties (from SD and CV values). The conservation of 
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intrinsic protein disorder was not reflected by Shannon’s entropy analysis[122], since 
there was no general observable trend between the dispersion of the average disorder 
score and Shannon’s entropy values (data not shown)[122]. In fact, Chen et al. have 
revealed Shannon’s entropy analysis to show relatively lower levels of sequence 
conservation in disordered regions compared to non-disordered regions[51]. This 
suggested that the conservation of protein disorder may capture some functional 
aspects of NFκB proteins not reflected via residue conservation. I therefore propose 
the use of the standard deviation (SD) and/or coefficient of variation (CV) as a more 
appropriate measure of determining the conservation of protein disorder, since they 
take into account the conservation of intrinsic protein disorder as a general 
characteristic, possibly encompassing physiochemical and structural properties rather 
than a residue-specific characteristic.  
Taken together, the results suggested that evolutionarily conserved disordered 
residues offer an alternative perspective on the functional roles of NFκB proteins, 
especially in facilitating binding events including DNA binding, ankyrin protein 
binding and possibly the binding of other proteins (from the discovery of disordered 
α-helix insert regions). However, conserved non-disordered residues do also 
contribute to specific NFκB functions. This highlighted that protein functions in 
NFκB transcription factors are not all necessarily affected through protein disorder. 
Rather, specific localizations of disordered and non-disordered residues in each 
functional site contribute to various aspects protein function, and each residue type 
plays unique, specific functional roles.  
Taking this view, intrinsic protein disorder signatures may be critical in determining 
protein function. In this study, it has been shown that differences in intrinsic protein 
signatures in both classes may account for their differences in mechanism between 
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both classes of NFκB proteins. These differences may possibly even between different 
types of proteins, as seen from certain exceptions in disorder signatures mentioned in 
Section 5.3. The monomeric composition of the NFκB dimers has been found to 
affect its DNA-binding site specificity, subcellular localization, trans-activation 
potential and mode of regulation, thus leading to combinatorial diversity of the 
downstream responses[63,136]. Here, intrinsic protein disorder signatures for each 
NFκB protein type may account for the variability in function for each type of NFκB 
dimer. 
 
5.5 Future Work 
This research demonstrated how the analysis of protein disorder can be applied to 
study the function of transcription factors such as the NFκB protein family, which are 
involved in many important cellular and organismal processes.  Further experimental 
validation and characterization of these predicted disordered residues, through both 
computational and laboratory means, are necessary to support the functional roles of 
these conserved disordered (and/or non-disordered) residues.  
Experimentally, imaging approaches can be used to observe in more detail the 
dynamics involved in NFκB interactions. Mutagenesis studies can be performed on 
conserved disordered residues to observe the change in function. Also, systems 
biology approaches integrating both experimental and computational methods can be 
utilized in the future for modeling and understanding NFκB interactions and 
pathways. 
Computationally, datasets on additional protein families can be used as positive and 
negative controls for a more robust analysis. These control datasets can also be used 
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to rigorously test the use of SD and/or CV as a quantifying measure of the 
conservation of intrinsic protein disorder.  
In addition, the value of using unique disorder motifs for protein families (in the form 
of matrices) for functional prediction, using approaches such as machine learning 
methods, can be investigated. If it can be demonstrated that protein families indeed 
have distinct disorder patterns, a database of these signatures can be developed for the 
benefit of the scientific community. 
Lastly, more in-depth structural analysis can be conducted to lend support to the 
findings in this study. More work can be done to quantify the correlation between 
intrinsic protein disorder and β-factors. Smith et al. advised on normalizing β-factors 
for more accurate comparisons[130]. The same procedure can be applied to this study 
in the future. Further structural analysis can also include molecular dynamics 
simulations and probabilistic conformational space sampling of known NFκB 
interacting structures, to investigate the effects and functional implications of 
interactions involving intrinsically disordered residues on permitted NFκB protein 
conformations. 
 
5.6 Chapter Conclusion 
Protein disorder has been implicated in various regulatory functions in the cell, 
particularly in transcription and cell signaling, allowing for the accommodation of 
multiple interaction partners and modification sites and the provision of flexibility in 
regulation[15,16]. In this study, I have described a study aimed at investigating the 
functional role of intrinsically disordered regions in NFκB proteins, a set of 
eukaryotic transcription factors involved in diverse cellular and organismal processes. 
I have examined the conservation of predicted disordered regions across known 
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representative NFkB protein sequences and analyzed the sequence and structural 
configuration of these disordered residues. From this study, distinctive protein 
disorder patterns across each NFκB protein type conserved across different species 
were observed, potentially highlighting key differences in mechanism and function 
between NFκB protein classes and types. Intrinsic protein disorder study therefore 
provides a different perspective in gaining more in-depth understanding of the 






For my thesis, I have developed an analysis pipeline, comprising computational 
prediction, data mining and sequence and structure analysis, to investigate the 
functional role of intrinsic protein disorder in the exemplar NFκB protein family.  
The pipeline represents the first critical step in analyzing and understanding intrinsic 
protein disorder and its role in protein function. Quantitative and qualitative findings 
of this project supported the emerging paradigm that the dynamics of signaling 
proteins in general, play important roles in modulating their functions. Protein 
disorder thus offers a new way of analyzing and understanding protein-protein 
binding and interactions, contributing to the further understanding of functional 
conservation in relatively diverse proteins.  
One exciting and meaningful implication of this project is that protein families may 
possess distinctive disorder signatures or motifs, which can prove valuable for 
functional characterization. To this end, the protein disorder analysis pipeline 
outlined, once established, can be applied to study the conservation and configuration 
of dynamic residues in other transcription factors and protein families. Key questions 
that can be addressed in future can include those pertaining to the complexity of 
transcription regulation machinery and signaling pathways encompassing signal 
integration and cross-talk.  
The methodology and findings of this study will lay the foundation to similar research 
in the future, thereby contributing significantly to research in the field of 
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